Altamira Therapeutics Ltd. Price & Performance (CYTO)
Stock Performance
Altamira Therapeutics Ltd.
$0.30USD
-$0.16 (-34.12%)
After Hours
-$0.30 (-100%)
- $0.42
- $1.13M
- $3.49
- $0.42
- 0.2
- $0.07
- $0.30
- 0.00%
- 724.30K
Open
Market Cap
Year High
High
P/E Ratio
Year Low
Low
Dividend Yield
Volume
What's Happening
Peers
Income Statement
Revenue
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
Revenue | -CHF 56K | CHF 174K | CHF 64K | CHF 306K | CHF 0 |
Cost of Revenue | CHF 0 | CHF 0 | CHF 2.2M | CHF 1.4M | CHF 0 |
Gross Profit | -CHF 56K | CHF 174K | -CHF 2.2M | -CHF 1.1M | CHF 0 |
Gross Profit % | 100% | 100% | -3.4K% | -372% | 0% |
R&D Expenses | CHF 3.3M | CHF 2.9M | CHF 8.9M | CHF 20M | CHF 3M |
Cash Flow
Net Income
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
Net Income | -CHF 6.6M | -CHF 8.2M | -CHF 17M | -CHF 27M | -CHF 3.9M |
Dep. & Amort. | CHF 31K | CHF 20K | CHF 76K | CHF 119K | CHF 119K |
Def. Tax | -CHF 194K | -CHF 21K | CHF 22K | -CHF 10K | -CHF 100K |
Stock Comp. | CHF 227K | CHF 369K | CHF 1.2M | CHF 343K | CHF 0 |
Chg. in WC | -CHF 1.2M | CHF 301K | CHF 511K | CHF 3.6M | -CHF 4.2M |
Balance Sheet
Cash
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
Cash | CHF 1.4M | CHF 11M | CHF 984K | CHF 15K | CHF 617K |
ST Investments | CHF 0 | CHF 0 | CHF 0 | CHF 0 | CHF 0 |
Cash & ST Inv. | CHF 1.4M | CHF 11M | CHF 984K | CHF 15K | CHF 617K |
Receivables | CHF 0 | CHF 0 | CHF 22K | CHF 6.5K | CHF 75K |
Inventory | -CHF 988M | -CHF 358M | CHF 839K | CHF 12K | CHF 0 |
Related
Financial information provided by Financial Modeling Prep. Options data provided by Unusual Whales. Live transcripts provided by Quartr. Reported revenue and EPS data from Earnings powered by FinChat.io. All data is provided for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. · See all tickers.